Nonna V. Kolomeyevskaya

Roswell Park Cancer Institute

Department of Gynecologic Oncology

Elm & Carlton Streets

Buffalo, NY 14263

716-***-****

Address:

*** ***** **. ***. # ***

Buffalo, NY 14201

617-***-****

acq209@r.postjobfree.com

EDUCATION

Postgraduate: 2011 -2015 Fellowship in Gynecologic Oncology

Roswell Park Cancer Institute

Buffalo, NY

2007-2011 Residency in Obstetrics and Gynecology

Baylor College of Medicine, Houston, TX

Graduate: 2003-2007 Doctor of Medicine

Albany Medical College, Albany, NY

Class Rank: Top-third

Undergraduate: 2001-2003 Bachelor of Arts (Biology)

Boston University, Boston, MA

Magna cum Laude

AWARDS AND HONORS

2013 Roswell Park Cancer Institute Award, the Best Basic Science Report

2010 Won the 2nd Prize for the research project, “A Novel Small Molecule

Inhibitor Of Aurora Kinase A Inhibits Growth and Metastasis of Cervical Cancer In Vitro and In Vivo”.

Arthur M. Faris, Sr., M.D. Resident Research Day

Baylor College of Medicine, Dept of OB/GYN. Houston, TX

2009 Felix Rutledge Fellowship U.T.M.D. Anderson Cancer Center

Houston, TX

2005-2006 PFC William J. Walker Jr. Endowed Scholarship

Albany Medical College, NY

Awarded for excellent academic performance

2005-2006 Dr. Harvey W. Kausel Memorial Scholarship

Albany Medical College, NY

Awarded for excellent academic performance

2003-2005 Horoshack Scholarship

Albany Medical College, NY

Awarded for excellent academic performance

2003-2004 Frank C. Knievel Memorial Fund

Albany Medical College, NY

Awarded for excellent academic performance

2001-2003 Boston University Trustee Scholarship

Boston University, MA

Awarded for excellent academic performance

2001-2002 Dean’s List (Fall 2001, Spring 2002, Fall 2002)

Boston University, Boston, MA

GRANTS

2008 Arthur M. Faris Grant for the Resident Research

Baylor College of Medicine, Houston, TX

PROFESSIONAL MEMBERSHIPS

2007-Present American College of Obstetrics and Gynecology. Junior Fellow

2011-Present Society of Gynecologic Oncologists.

RESEARCH

Mentors: Kunle Odunsi, M.D., Ph.D. and Brahm H. Segal, M.D.

Present Clinico-pathologic correlation of mitochondrial DNA and cytokine

levels in EOC ascites. Prognostic implication.

PUBLICATIONS

1.Ajenifuja K, Kolomeyevskaya N, Habib F, Odunsi A, Lele S. Phyllodes tumor of the breast metastasizing to the vulva. Case Rep Oncol Med. 2015;2015:589547. Epub 2015 Apr 15.PMID: 25960902.

2.Khan AN, Kolomeyevskaya N (1st Co-Author), Singel KL, Grimm MJ, Moysich KB, Daudi S, Grzankowski KS, Lele S, Ylagan L, Webster GA, Abrams SI, Odunsi K, Segal BH. Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer. Oncotarget. 2015 May 10;6(13):11310-26. PMID:25888637

PROVISIONAL PATENT APPLICATION WAS FILED BASED ON THIS WORK.

3.N. V. Kolomeyevskaya, G. Zirpoli, Shashikant B. Lele MD, Kunle O.

Odunsi, MD PhD, Albina Minlikeeva, MPH, Grace Friel, MA, Rikki A.

Cannioto, MS EdD, Kassondra S. Grzankowski, MD, J. Brian Szender, MD,

Rachel M. Brightwell, MD, and Kirsten B. Moysich PhD. Oral contraceptive

use and reproductive characteristics affect survival in patients with epithelial

ovarian cancer. Accepted for publication in International Journal of

Gynecologic Cancers.

4.Kolomeyevskaya N, Eng KH, Khan AN, Grzankowski KS, Singel KL, Moysich K, Segal BH. Cytokine Profiling of Ascites at Primary Surgery Identifies an Interaction of Tumor Necrosis Factor-alpha and Interleukin-6 in Predicting Reduced Progression-Free Survival in Epithelial Ovarian Cancer. Gynecol Oncol. 2015 May 20. pii: S0090-8258(15)00914-2. doi: 10.1016/j.ygyno.2015.05.009. [Epub ahead of print]. PMID: 26001328

5.Nonna V. Kolomeyevskaya, Shashikant B. Lele, Austin Miller, Grazyna C. Riebandt, Bonnie L. Blum, Kunle Odunsi, and Peter J. Frederick. Oxaliplatin is a safe alternative option for patients with recurrent gynecologic cancers following hypersensitivity reaction to carboplatin. Int J Gynecol Cancer. 2015 Jan;25(1):42-8. PMID: 25356535

6.Friel G, Liu C, Kolomeyevskaya N(2nd Co-Author), Lele S, Odunsi KO, Schmitt K, Kruszka B, Moysich KB. Aspirin and Acetaminophen decrease the risk of cervical cancer in long-term users. J Low Genit Tract Dis. 2015 Jul;19(3):189-93. PMID: 25856123

7.Current Multidisciplinary Oncology: Gynecologic Cancers: A Multidisciplinary Approach to Diagnosis and Management (Current Multidisciplinary Oncology). Chapter 12, “Multidisciplinary Approach to Diagnosis and Treatment of Uterine Sarcomas”. Matthew L. Anderson and Nonna Kolomeyevskaya. P.83-92. Kunle Odunsi MD, Tanja Pejovic MD, Charles Thomas Jr. MD

8.Heidi E. Godoy, A. Nazmul H. Khan, R. Robert Vethanayagam, Melissa J. Grimm, Kelly L. Singel, Nonna Kolomeyevskaya, Kevin J. Sexton, Anupama Parameswaran, Nikolaos G. Almyroudis, Scott I. Abrams, Kunle Odunsi, and Brahm H. Segal. Myeloid-derived suppressor cell modulate immune responses independently of NADPH oxidase in the ovarian tumor microenvironment in mice. PLoS One. 2013; 26;8(7):e69631

PMID: 23922763

9.Francis JC, Kolomeyevskaya N, Mach CM, Dietrich JE, Anderson ML. MicroRNAs and Recent Insights into Pediatric Ovarian Cancers. Front Oncol. 2013 Apr 30;3:95. PMID: 23641362.

10.Kolomeyevskaya, N and Anderson, ML. Evaluating the Role of Pulmonary Metastasectomy in the Treatment of Gynecologic Sarcomas.

Salud(i) Ciencia 2014; 20:518-520. Published in the Journal, Sociedad Iberoamericana de Informacion Cientifica. www.siicsalud.com

11.Shan W, Akinfenwe PY, Brewer SK, Kolomeyevskaya N, Laucirica R, Thomas D, Odunsi K, Creighton C, Lev D, Anderson M. A Small Molecule Inhibitor Targeting the Mitotic Spindle Checkpoint Impairs the Growth of Uterine Leiomyosarcoma. Clin Cancer Res.2012;18(12):3352-65.

PMID: 22535157.

12.Kolomeyevskaya N, Miller HJ, Anderson ML, Patsner B.

The “Nested Suture” Technique for Achieving Hemostasis After Cold-Knife

Conization of the Cervix During Pregnancy.

Journal of Gynecologic Surgery 2011;27(3):193-197

13.Kolomeyevskaya NV, Tanyi JL, Coleman NM, Beasley AD, Miller HJ, Anderson ML. Balloon tamponade of hemorrhage after uterine curettage for gestational trophoblastic disease. Obstet Gynecol. 2009 Feb;113(2 Pt 2):557-60.

PMID: 19155956.

14.Kolomeyevskaya N, Blazo M, Van den Veyver I, Strehlow S, Aagaard-

Tillery K. Pheochromocytoma and Von Hippel-Lindau in pregnancy.

Am J Perinatol. 2010 Mar;2(3):257-63.

PMID: 19784914.

ABSTRACTS

N. V. Kolomeyevskaya, G. Zirpoli, M. Ruszczyk, K. S. Grzankowski, S. B. Lele,

K. O. Odunsi and K. Moysich. Oral contraceptive use and reproductive

characteristics affect survival in patients with epithelial ovarian cancer.

Poster presentation. Society of Gynecologic Oncology.

2015. Chicago, IL.

Kassondra S. Grzankowski MD, Nazmul H. Khan MBBS PhD, Nonna V.

Kolomeyevskaya MD, Kevin H. Eng PhD, Kirsten Moysich, PhD., Kunle O.

Odunsi MD PhD, and Brahm H. Segal MD. Serum mitochondrial DNA shows a

greater effect size than CA-125 in predicting survival in epithelial ovarian

cancer. Plenary presentation. Society of Gynecologic Oncology. 2015.

Chicago, IL.

Friel G, Liu C, Kolomeyevskaya N, Moysich KB. Aspirin and acetaminophen

decrease the risk of cervical cancer in long-term users.

Featured Poster Presentation at the 86th Annual Meeting on Women’s Cancer

(SGO), Tampa FL, March 21-24, 2014.

Cici Liu, Grace Friel, Nonna Kolomeyevskaya, Shashi Lele, Kunle Odunsi,

Kirsten Moysich. Aspirin and acetaminophen decrease the risk of cervical

cancer in long-term users. 47th Annual Meeting of the Society for

Epidemiologic Research. Seattle, WA. June 24-27, 2014

N. V. Kolomeyevskaya, N. Khan, R. Dolnick, S. Abrams, K. O. Odunsi, S. B.

Lele and B. H. Segal. Cytokine profiling of ascites identifies Macrophage

inflammatory protein- beta and Tumor necrosis factor –alpha as predictors of

progression-free survival in patients with epithelial ovarian cancer. Poster

Presentation at the 86th Annual Meeting on Women’s Cancer (SGO), Tampa

FL, March 21-24, 2014.

N. V. Kolomeyevskaya, S. B. Lele, A. Miller, G. Riebandt, B. Blum, K.

Hacker, S. N. Akers, K. O. Odunsi, and P. J. Frederick. Oxaliplatin is a safe

alternative for patients with recurrent gynecologic cancers following

hypersensitivity reaction to carboplatin. Poster Presentation at the 86th

Annual Meeting on Women’s Cancer (SGO), Tampa FL, March 21-24, 2014.

N. V. Kolomeyevskaya, N. Khan, M. Grimm, K. Singel, K.S. Grzankowski,

S. Abrams, K. O. Odunsi, and B. H. Segal. Targeting myeloid cells in the

tumor microenvironment as a strategy to enhance vaccine efficacy in the

epithelial ovarian cancer. Poster Presentation at the 86th

Annual Meeting on Women’s Cancer (SGO), Tampa FL, March 21-24, 2014.

Grzankowski KS, Khan AN, Grimm M, Hylander B,. Singel KL, Moysich

KB, Kolomeyevskaya N, Odunsi K, Segal BH. Pre-treatment serum

mitochondrial DNA (mtDNA) correlates with shorter progression-free and

overall survival in patients with advanced ovarian cancer (OC).

Poster Presentation at the 50th ASCO conference.Chicago, IL, May 30, 2014.

Kassondra S. Grzankowski MD, Anm Nazmul H. Khan MBBS PhD, Kevin

Eng PhD, Melissa Grimm, PhD, Bonnie Hylander PhD, Kelly L. Singel BS,

Kirsten Moysich PhD, Nonna Kolomeyevskaya MD, Kunle Odunsi MD,

PhD, Brahm H. Segal MD. Mitochondrial DAMPs activate neutrophils and

High levels predict worse outcome in patients with advanced ovarian cancer.

Poster Presentation at the 13th Annual Buffalo Conference on Immunology,

Mayville, NY, March 31, 2014.

Khan AN, Singel KL, Kolomeyevskaya N, Grimm MJ, Franklin D, Lele

SB, Abrams SI, Odunsi K, Segal BH. Myeloid cell-mediated

Immunosuppression in the ovarian cancer microenvironment.

Immunology Retreat 2013. Holiday Valley, Buffalo, NY.

Shan W, Akinfenwa PY, Brewer KJ, Kolomeyevskaya N, Laucirica R,

Lev DC, and Anderson ML. Dysregulation of the Mitotic Spindle

Checkpoint Contributes to the Development of Human Genital Tract

Leiomyosarcoma. Poster Presentation at the 102nd Annual Meeting of

AACR (American Association for Cancer Research) 2011. April 2011.

Akinfenwa PY, Kolomeyevskaya NV (1st Co-Author), Mach CM,

Zhen L, and Anderson ML. A Novel Small Molecule Inhibitor for

Aurora-A Kinase Inhibits the Growth of Cervical Cancer In Vitro and

In Vivo. Poster Presentation at the 43rd Annual Meeting of SSR (Society for

the Study of Reproduction). July 2010.

Plevyak MP, Kolomeyevskaya N, Malee MP, Veille JC. Abstract.

Antenatal factors affecting survival and neonatal morbidity at the

threshold of viability. Reproductive Sciences 2005, Vol. 12, No.2 suppl,

22A-82A. Poster Presentation at the 52nd Annual meeting of the Society for

Gynecologic Investigation. March 2005.

ORAL PRESENTATIONS

2010 “A Novel Small Molecule Inhibitor Of Aurora Kinase A Inhibits Growth

and Metastasis of Cervical Cancer In Vitro and In Vivo”.

Arthur M. Faris, Sr., M.D. Resident Research Day

Baylor College of Medicine, Dept of OB/GYN. Houston, TX

Won 2nd Prize

2009 “Comparison of FIGO and AJCC staging systems for Uterine

Leiomyosarcoma”.

U.T.M.D. Anderson Cancer Center, Houston, TX

2009 “Malignant Ovarian Tumors in Children and Adolescents”.

Division of Pediatric and Adolescent Gynecology

Baylor College of Medicine, Houston TX

TEACHING

2012-2013 Gave lectures on Gynecologic Cancers to students enrolled in

Master of Science and PhD program at University of Buffalo

2009-2011 Gave medical students lectures on ovarian cancer as

part of their OB/GYN curriculum

Baylor College of Medicine. Houston, TX

2004-2005Medical student coach

Albany Medical College. Albany, NY

EMPLOYMENT

2003 Assistant Project Manager

Science Applications International Corporation, Boston, MA

Participated in project design to evaluate community hospitals in the state

of Massachusetts.

LANGUAGES :

English, Russian, medical Spanish

Worked as a professional interpreter in Russia: translated research

articles, dissertations, documents, contracts; interpreted during meetings

and conferences.

Contact this candidate